Effect of zoledronic acid in hepatic osteodystrophy: A double-blinded placebo-controlled trial

Effect of zoledronic acid in hepatic osteodystrophy: A double-blinded placebo-controlled trial

Purpose: Literature on the treatment of pre-transplant hepatic osteodystrophy (HOD) is limited. The general treatment measures and their timing are currently adopted from the literature on postmenopausal osteoporosis. Therefore, we conducted this randomized study to investigate the effect of zoledro...

Full description

Bibliographic Details
Main Authors:	Henith Raj, Sadishkumar Kamalanathan, Jayaprakash Sahoo, Pazhanivel Mohan, Krishnan Nagarajan, Sagili V B. Reddy, Harsh Durgia, Rajan Palui
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	bone mineral density bone turnover markers hepatic osteodystrophy trabecular bone score zoledronic acid
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2023;volume=27;issue=6;spage=552;epage=558;aulast=Raj

Similar Items

Response to zoledronic acid in patients with active Paget's disease of bone: A retrospective study
by: Harsh Durgia, et al.
Published: (2019-01-01)

Investigation of renal osteodystrophy among hemodialysis patients referring to Towhid Hospital, Sanandaj, Iran
by: Vahid Sedighi-Gourabi, et al.
Published: (2014-06-01)

Bone marrow adiposity inversely correlates with bone turnover in pediatric renal osteodystrophy
by: Ornatcha Sirimongkolchaiyakul, et al.
Published: (2021-12-01)

The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study
by: Alireza Dabbaghmanesh, et al.
Published: (2023-11-01)

A comparative study of bone biopsies from the iliac crest, the tibial bone, and the lumbar spine
by: Ruth G. G. Hiller, et al.
Published: (2017-04-01)

The Evaluation of Renal Osteodystrophy in Patients on Hemodialysis by Biochemical and Radiological Methods
by: Sibel Mandıroğlu, et al.
Published: (2013-04-01)

Examining zoledronic acid for the prevention of bone loss in patients receiving bariatric surgery
by: Yi Liu, et al.
Published: (2021-06-01)

Renal osteodystrophy: A historical review of its origins and conceptual evolution
by: Garabed Eknoyan, et al.
Published: (2022-12-01)

Changes in cortical bone channels network and osteocyte organization after the use of zoledronic acid
by: Gustavo Davi Rabelo, et al.
Published: (2015-08-01)

Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
by: Allen Herng Shouh Hsu, et al.
Published: (2022-03-01)

Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment
by: Adriano L. Spirlandeli, et al.

Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease
by: Yogesh Karoli, et al.
Published: (2016-08-01)

Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy Signatures
by: John D. Ciubuc, et al.
Published: (2018-04-01)

Comparison of biochemical markers of bone turnover in patients on continuous ambulatory peritoneal dialysis and maintenance hemodialysis
by: Novaković Neda, et al.
Published: (2007-01-01)

Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
by: Yanjuan Huang, et al.
Published: (2020-12-01)

Mandibular hypertrophic osteodystrophy fibrosa in a german shepherd puppy
by: Elham HASSAN, et al.
Published: (2019-07-01)

Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
by: Ashley A. Smith, et al.
Published: (2023-01-01)

Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease
by: A.T.A. Taveira, et al.
Published: (2010-11-01)

Effect of Systemic Zoledronic Acid Dosing Regimens on Bone Regeneration in Osteoporotic Rats
by: Marwa Y. Shaheen, et al.
Published: (2021-02-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Prevalence and Pattern of Renal Osteodystrophy in Chronic Hemodialysis Patients: A Cross Sectional Study of 103 Patients
by: Buargub Mahdia, et al.
Published: (2006-01-01)

Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
by: Tsan-Wen Huang, et al.
Published: (2017-05-01)

Development of 166Ho-zoledronate as a bone marrow ablative agent
by: Mirsaeed Nikzad, et al.
Published: (2016-02-01)

Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease
by: Eman Nagy, et al.
Published: (2022-11-01)

Bone Morphogenetic Protein 2 Promotes Bone Formation in Bone Defects in Which Bone Remodeling Is Suppressed by Long-Term and High-Dose Zoledronic Acid
by: Young Jae Moon, et al.
Published: (2023-01-01)

Zoledronate Bound to Ceramics Increases Ectopic Bone Volume Induced by rhBMP6 Delivered in Autologous Blood Coagulum in Rats
by: Nikola Stokovic, et al.
Published: (2021-10-01)

Mineral and bone disorders secondary to chronic kidney disease (renal osteodystrophy)
by: Alphonsus N. Onyiriuka, et al.
Published: (2015-02-01)

Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy
by: Irma Machuca-Gayet, et al.
Published: (2020-04-01)

Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study
by: Guang‐tao Fu, et al.
Published: (2019-08-01)

Giant cell tumour of bone in os sacrum of a prepubertal girl – Surgical and medical treatment with zoledronate and denosumab
by: Signe Sparre Beck-Nielsen, et al.
Published: (2023-06-01)

Two-year effectiveness of zoledronic acid with or without eldecalcitol in Japanese patients with osteoporosis: A randomized prospective study
by: Takeshi Mochizuki, et al.
Published: (2022-06-01)

Renal osteodystrophy and clinical outcomes: a prospective cohort study
by: Cinthia Esbrile Moraes Carbonara, et al.
Published: (2023-10-01)

Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis
by: Justin-Pierre Lorange, et al.
Published: (2023-04-01)

ZOLEDRONIC ACID ADMINISTRATION ENHANCES FRACTURE HEALING IN THE OSTEOPOROTIC FRACTURES IN OVARIECTOMIZED RABBITS
by: Cansabuncu Gokhan, et al.
Published: (2019-05-01)

A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial
by: Chia-Che Lee, et al.
Published: (2021-09-01)

Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
by: Mari I. Suominen, et al.
Published: (2023-08-01)

A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis
by: Sandhya Y., et al.
Published: (2023-07-01)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
by: Ibrahim Toni, et al.
Published: (2012-11-01)

Paget’s Disease in an Omani: Long-term Improvement Following a Single Injection of Zoledronic Acid
by: Omayma Elshafie, et al.
Published: (2016-03-01)

Bone Disorders in Pediatric Chronic Kidney Disease: A Literature Review
by: Lavinia Capossela, et al.
Published: (2023-11-01)